Functional imaging of ovarian cancer and peritoneal carcinomatosis
Functional Imaging in Oncology: Clinical Applications - Volume 2, Page: 877-900
2014
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures1
- Readers1
Book Chapter Description
Imaging plays an integral role in the diagnosis and management of ovarian cancer. The value of conventional anatomical modalities, such as ultrasonography (US), computed tomography (CT) and magnetic resonance imaging (MRI), in the detection, characterisation and staging of ovarian pathology is widely established in clinical practice. Current advances in imaging include the supplementation of pure morphological depiction at a macroscopic level with visualisation and quantification of functional properties of tissue, in an effort to provide noninvasive biomarkers of disease activity and its response to treatment. Modalities, such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced MRI (DCE-MRI), proton magnetic resonance spectroscopy (1H-MRS), [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) and molecularly targeted PET radiotracers, radioimmunoscintigraphy (RIS) and near-infrared (NIR) optimal imaging, explore the microstructure, perfusion, biochemical composition and metabolism of ovarian tumours in vivo; their impact in diagnosis, surveillance and treatment planning and monitoring are mostly under investigation. This chapter reviews the functional imaging techniques employed in ovarian cancer and peritoneal carcinomatosis in the clinical and experimental setting and discusses their advantages, limitations and potential utility in improving management strategies.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84956750948&origin=inward; http://dx.doi.org/10.1007/978-3-642-40582-2_13; https://link.springer.com/10.1007/978-3-642-40582-2_13; https://dx.doi.org/10.1007/978-3-642-40582-2_13; https://link.springer.com/chapter/10.1007/978-3-642-40582-2_13
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know